Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL406639 | 0.77 | CHRM2 (0.34) | SLC1A2CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL10022762 | 0.74 | MGLL (0.33) | ALDH1A1 | |
| SCHEMBL10022759 | 0.70 | MME (0.33) | — | |
| SCHEMBL18073624 | 0.69 | CHRM2 (0.37) | SLC1A2CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL1536266 | 0.69 | CHRM2 (0.37) | SLC1A2CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL19286980 | 0.69 | CHRM2 (0.37) | SLC1A2CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL1698550 | 0.68 | SMN1; SMN2 (0.41) | SLC1A2CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL8024903 | 0.67 | CHRM2 (0.36) | SLC1A2CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL10644061 | 0.66 | CHRM2 (0.38) | SLC1A2CHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL14802499 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9513284-B2 | Pyrenyloxysulfonic acid fluorescent agents | Life Technologies Corporation (US) | 2016-12-06 | — | — | US | disclosed |
| US-20140193926-A1 | PYRENYLOXYSULFONIC ACID FLUORESCENT AGENTS | Life Technologies Corporation (US) | 2014-07-10 | — | — | US | disclosed |
| US-8476461-B2 | Dipyrromethene-boron hydrophilic fluorescent compounds | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2013-07-02 | — | — | US | disclosed |
| US-8268886-B2 | Pyrenyloxysulfonic acid fluorescent agents | Life Technologies Corporation (US) | 2012-09-18 | — | — | US | disclosed |
| US-20120045848-A1 | PYRENYLOXYSULFONIC ACID FLUORESCENT AGENTS | Life Technologies Corporation (US) | 2012-02-23 | — | — | US | disclosed |
| US-20120009615-A1 | DIPYRROMETHENE-BORON HYDROPHILIC FLUORESCENT COMPOUNDS | UNIVERSITE DE STRASBOURG (50% PART INTEREST) (FR) | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120045848-A1 | PYRENYLOXYSULFONIC ACID FLUORESCENT AGENTS | NOP56, ANXA5, ANXA6 | SLC1A2 4215/4885CHRM2 2686/4885CHRM4 1670/4885 |
| US-20120009615-A1 | DIPYRROMETHENE-BORON HYDROPHILIC FLUORESCENT COMPOUNDS | LDHB, AHR, BCR | SLC1A2 1316/4885CHRM2 2731/4885CHRM4 3578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.